AM

Aaliya Mohd Khalil Khan

Active Director Director DIN 09672451
DIN 09672451 First appointment Jul 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Aaliya Mohd Khalil Khan

Data last updated:

Aaliya Mohd Khalil Khan is a Director at Medeprase Mimex Private Limited (since 2022). The company operates in Healthcare.

DIN 09672451
Primary Designation Director
Industry Healthcare
First Appointment 13 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medeprase Mimex Private Limited U33100MH2022PTC386654
Director13 Jul 20222022Active

Board colleagues of Aaliya Mohd Khalil Khan

NameDINCompanyDesignation
Shadab Sadruddin Khan07877335Medeprase Mimex Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medeprase Mimex Private Limited
Premium access

Shareholding and investment profile for Aaliya Mohd Khalil Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aaliya Mohd Khalil Khan

Aaliya Mohd Khalil Khan currently holds 1 directorship: Medeprase Mimex Private Limited (Director, since 13 Jul 2022).

Aaliya Mohd Khalil Khan was first appointed on 13 Jul 2022 as Director at Medeprase Mimex Private Limited.

The current boards of Aaliya Mohd Khalil Khan's companies include Shadab Sadruddin Khan (Medeprase Mimex Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available